Covid vaccines: US regulator sceptical over AstraZeneca model

Vaccine developed in Oxford criticised by FDA with efficacy rates and trials delaying official take-upCoronavirus – latest updatesSee all our coronavirus coverageFor a man presenting landmark results from trials of a vaccine that it is hoped will save the world from a devastating pandemic, Sir Menelas Pangalos did not look cheerful on Wednesday.Pangalos, executive vice-president of biopharmaceuticals R&D at AstraZeneca, and his colleagues are undoubtedly exhausted, having been working round the clock on the coronavirus vaccine with Oxford University since April. But they are now dealing with a sizeable new headache – the doubts of the US regulator. Continue reading... https://www.theguardian.com/business/2020/dec/09/covid-vaccines-us-regulator-sceptical-over-astrazeneca-model #coronavirus #astrazeneca #university_of_oxford #uk_news #us_news #pharmaceuticals_industry #science #world_news